No abstract available
MeSH terms
-
Ado-Trastuzumab Emtansine
-
Antibodies, Monoclonal, Humanized / pharmacology
-
Antineoplastic Agents / adverse effects*
-
Antineoplastic Agents / metabolism
-
Brentuximab Vedotin
-
Cytotoxins / adverse effects*
-
Cytotoxins / metabolism
-
Humans
-
Immunoconjugates / pharmacology
-
Immunotoxins / immunology
-
Immunotoxins / pharmacology*
-
Maytansine / analogs & derivatives
-
Maytansine / pharmacology
-
Trastuzumab
Substances
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents
-
Cytotoxins
-
Immunoconjugates
-
Immunotoxins
-
Maytansine
-
Brentuximab Vedotin
-
Trastuzumab
-
Ado-Trastuzumab Emtansine